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Abstract 
Objective:  Biomedical interest in brown adipose tissue (BAT) has increased since 
the discovery of functionally active BAT in adult humans. While white adipose tissue 
(WAT) influences vascular function, vascular effects of BAT are elusive. Thus, we 
investigated the regulatory role and putative vasoprotective effects of BAT, focusing 
on hydrogen peroxide (H2O2), NAPDH-oxidase 4 (Nox4) and redox-sensitive 
signaling. 
Approach/Results: Vascular reactivity was assessed in wild-type (WT) and Nox4-
knockout mice (Nox4-/-) by wire myography in the absence and presence of 
perivascular adipose tissue (PVAT) of different phenotypes from various adipose 
depots: i) mixed WAT/BAT (inguinal adipose tissue (iWAT)), ii) WAT (epididymal 
visceral fat (EVAT)) and BAT (intrascapular fat). In WT mice, EVAT and PVAT 
increased EC50 to noradrenaline (NA) without affecting maximum contraction. BAT 
increased EC50 and significantly decreased maximum contraction, which were 
prevented by an H2O2 scavenger (PEG-catalase) and a specific PKG-1α inhibitor 
(DT-3), but not by inhibition of eNOS or guanylate cyclase. BAT induced dimerization 
of PKG-1α and reduced phosphorylation of myosin light chain phosphatase subunit 1 
(MYPT-1) and myosin light chain 20 (MLC-20). BAT from Nox4-knockout mice 
displayed reduced H2O2 levels and no anticontractile effects. PVAT from β3-agonist 
treated mice displayed browned PVAT and an increased anticontractile effect. 
Conclusions: We identify a novel vasoprotective action of BAT through an 
anticontractile effect that is mechanistically different to WAT. Specifically, BAT, via 
Nox4-derived H2O2, induces PKG-1α activation, resulting in reduced vascular 
contractility. BAT may constitute an interesting therapeutic target to restore vascular 
function and prevent vascular complications in cardiovascular diseases. 
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Abbreviations and Acronyms 
5-HT   5-hydroxytryptamine, serotonin 
ACh   acetylcholine 
BAT   brown adipose tissue  
BeAT    beige adipose tissue 
BKCa   big conductance calcium sensitive potassium channel 
DTT    dithiothreitol 
EVAT    epididymal visceral adipose tissue 
FBX-10  F-box and leucine-rich repeat protein-10 
H2O2   hydrogen peroxide 
HRP   horse-radish peroxidase 
IPO8   importin 8 
iWAT    inguinal subcutaneous adipose tissue 
KCa   calcium sensitive potassium channel 
KPSS   potassium rich physiological saline solution 
L-NAME  NG-nitro-L-arginine methyl ester 
MLC   myosin light chain 
MYPT1  myosin light chain phosphatase subunit 1 
NA   noradrenaline 
NADPH  nicotinamide adenine dinucleotide phosphate 
Nox  NADPH oxidase 
NO   nitric oxide 
P2RX5  purinergic Receptor P2X 5 
PEG   polyethylene glycated 
Phe   phenylephrine 
PKG-1  cGMP dependent protein kinase G type-1 
PVAT   perivascular adipose tissue 
SNP   sodium nitroprusside 
SOD   superoxide dismutase 
TBX1   T-Box protein 1 
Tcf21   transcription factor 21 
TEA   tetraethylammonium 
TNF-α   tumor necrosis factor-α 
TMEM-26  transmembrane protein-26 
UBC   ubiquitin C  
WAT   white adipose tissue 
Zic1   zinc finger of the cerebellum 
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Introduction 
Until recently perivascular adipose tissue (PVAT) was regarded as a structural 
element responsible for support and mechanical protection of the associated vessel.  
However, in 1991, Soltis and Cassis demonstrated that PVAT influences vascular 
function by decreasing contractile responses in rat aorta.1 PVAT is now widely 
recognized as a functional regulator of vascular tone through its secretion of relaxing 
and constricting factors acting on the vasculature. Studies have suggested relaxing 
factors to be nitric oxide (NO),2 adiponectin,2-5 angiotensin 1-7,6, 7 prostacyclins,8 
hydrogen sulphide (H2S)9, 10 and hydrogen peroxide (H2O2).11, 12 These factors are 
counteracted by contracting factors such as superoxide anion (O2.-),13 tumor necrosis 
factor-α (TNF-α) and prostacyclins14 and the ultimate regulatory effect on vascular 
tone is reflected by the balance of PVAT-derived vasoconstrictor and vasodilator 
factors.15 
The final determinant of vascular contraction is the phosphorylation status of myosin 
light chain 20 (MLC20), which is regulated by myosin light chain kinase (MLCK) and 
myosin light chain phosphatase (MLCP). MLCP activity is inhibited by myosin light 
chain phosphatase regulatory subunit 1 (MYPT1) and MLCK activity is regulated by 
intracellular calcium (Ca2+) concentration. Counterbalancing vascular contraction is 
the vasodilatory pathway mediated by cGMP-dependent protein kinase G type 1 
(PKG-1).16 Classically, activation of PKG-1 is mediated via endothelium-dependent 
increases in cyclic GMP (cGMP), resulting in phosphorylation of big conductance 
calcium-sensitive potassium channels (BKCa) and decreased intracellular Ca2+. PKG-
1 also phosphorylates RhoA, resulting in reduced Rho kinase (ROCK) activity and 
consequent reduced phosphorylation of MYPT1. Together, these pathways converge 
on decreased phosphorylation of MLC20 and thereby reduce vascular contraction.17 
Recent studies have also implicated PKG-1 in the anticontractile effects of PVAT.5, 18 
Adipose tissue comprises two subtypes: white (WAT) and brown (BAT) adipose 
tissues. WAT is known for its capacity to store lipids and its endocrine role whereas 
BAT is characterized by energy expenditure in favor of heat generation (non-
shivering thermogenesis). Previously thought only to be present in newborns, BAT 
has recently been identified in adults.19, 20 In pathologies such as obesity and 
hypertension, WAT is characterized by low-grade inflammation and is associated 
with insulin resistance and vascular dysfunction.21, 22 These changes are also evident 
in PVAT where the anticontractile effect is lost23-30 resulting in a pro-contractile 
phenotype.23 We previously demonstrated, in experimental models of obesity-related 
type 2 diabetes, that PVAT-derived factors induce endothelial dysfunction and 
regulate vascular contractility and remodeling.31 These processes were associated 
with increased vascular inflammation and vascular smooth muscle cell 
proliferation.32-34  
A major source of both O2.- and H2O2 are the nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidases (Nox). Seven isoforms with tissue specific expression 
patterns have been identified and characterized including, Nox1, Nox2, Nox3, Nox4 
and Nox5 and the dual oxidases (DUOX) 1 and 2.35 Nox4 is the predominant isoform 
expressed in murine and human adipocytes. In adipose tissue however, both Nox2 
and Nox4 are expressed at the mRNA level.36-40 Nox4 produces mainly H2O2 
whereas the other Nox isoforms produces O2.-. This difference has 
pathophysiological relevance where H2O2-producing Nox4 activity has been shown 
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to have protective effects on the vasculature whereas O2.- producing Nox isoforms in 
many studies are shown to be detrimental.41, 42 While PVAT of resistance vessels is 
phenotypically characterized as WAT, the PVAT of the aorta is of a BAT 
phenotype.43 Periaortic BAT has anticontractile1, 26, 44 and anti-inflammatory 
properties in obesity, and may thus have vasoprotective effects.43 
In the present study, we examined the role of BAT on vascular function of small 
resistant arteries and we elucidated some of the underlying molecular mechanisms 
whereby BAT influences endothelial function and vascular contractility. Our study 
focuses on small resistance arteries, important in blood pressure regulation and 
development of hypertension. Arteries were exposed to adipose tissue from different 
adipose depots epididymal visceral adipose tissue (EVAT), which is phenotypically 
WAT, inguinal subcutaneous adipose tissue (iWAT) and mesenteric perivascular 
adipose tissue (PVAT) comprised of both WAT and BAT, and interscapular adipose 
tissue which is solely BAT. 
   
Materials and methods  
Materials and methods are available in the online data supplement. 
 
Results 
Phenotyping adipose tissue from different depots. 
iWAT, EVAT and mesenteric PVAT are generally characterised as WAT. However, 
since WAT can convert into a brown-like phenotype, called beige adipose tissue 
(BeAT), a small amount of BeAT may be present in adipose tissue classically 
considered as WAT. To confirm the nature of the adipose tissue that we studied, we 
investigated the adipose phenotype by analyzing mRNA levels of expression of 
leptin and transcription factor 21 (tcf21) as markers for WAT, zinc finger of the 
cerebellum (Zic1) and purinergic receptor P2X5 (P2RX5) as specific markers for 
BAT and transmembrane protein-26 (Tmem-26), Cd-137and T-box protein 1 (Tbx1) 
as specific markers for BeAT. Uncoupling protein-1 (Ucp-1) and transcription factor 
Pat2 are joint markers for both BAT and BeAT. These markers have been previously 
investigated and evaluated in the phenotyping of adipose tissue.45, 46 
Interscapular BAT displayed high expression of brown/beige markers UCP-1 and 
Pat2 as well as the specific markers Zic 1 and P2Rx5 (Supplemental figure I). iWAT 
expressed brown/beige marker UCP-1 and Pat2 (Supplemental figure I) as well as 
the specific markers for BeAT TMEM-26, Tbx1 and CD-137 (Supplemental figure II). 
EVAT displayed only white markers (Supplemental figure III). PVAT displayed 
expressed WAT specific marker tcf21 as well as BeAT specific marker Tbx-1 and 
Bat/BeAT marker Pat2 (Supplemental figure II and III). Hence, in our study, we used 
the paradigm that iWAT and PVAT display a mixed adipose phenotype whereas 
EVAT is primarily WAT. 
 
BAT exerts an anticontractile effect. 
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Contractile responses of mouse mesenteric arteries were evaluated using wire 
myography and showed that the presence of iWAT did not affect vascular 
contraction in response to increasing doses of noradrenaline (NA) (Figure 1A). The 
presence of mesenteric PVAT or EVAT increased the sensitivity (EC50) to NA but did 
not affect maximum contraction to NA (Figure 1B). However, the presence of BAT 
markedly reduced contraction to NA, phenylephrine (Phe) or serotonine (5-HT), 
demonstrating a potent anticontractile effect (Figure 1C, Supplemental Figures IV-A 
and IV-B). The anticontractile effect of BAT was independent of gender and 
background strain (Supplemental Figures IV-C and IV-D). 
 
H2O2 is among the anticontractile factors produced by BAT. 
A media transfer approach was used to investigate whether the anticontractile effect 
of BAT required its immediate localisation to the vessel or if the effect was mediated 
by a secreted factor. Transfer of media preconditioned with BAT displayed a similar 
anticontractile effect as BAT directly surrounding the vessel (Figure 1D), indicating 
the presence of a diffusible factor, secreted by BAT and acting in a paracrine 
manner. The presence of polyethylene glycated catalase (PEG-catalase), which 
scavenges H2O2, prevented the anticontractile effect of BAT (Figure 2A). Blockade of 
voltage-gated potassium channels (Kv) by 4-aminopyridine (4-AP) or XE-991, 
angiotensin 1-7 (Mas) receptors by A779, and production of hydrogen sulphide (H2S) 
by β-cyanoalanine did not influence the anticontractile effect of BAT (Supplemental 
Figure V). Also, endothelial denudation, blockade of production of prostacyclin by 
indomethacin did not affect the anticontractile effect of BAT (Supplemental figure VI-
A and B).  
 
BAT does not influence vascular relaxation. 
As demonstrated in supplemental figure VII, endothelium-dependent vascular 
relaxation in response to acetylcholine (Ach) and endothelium-independent 
relaxation in response to sodium nitroprusside (SNP) were not affected by BAT. 
 
Nox4 plays a role in BAT-secreted H2O2. 
As shown in Figure 2, Nox4 mRNA levels were increased in BAT and iWAT versus 
iWAT, but not Nox1 or Nox2. Protein expression of Nox4 was increased only in BAT 
(Supplementary figure VIII-D). Since Nox4 is a constitutively active producer of H2O2 
we further explored the possibility that Nox4 may be important in vascular tone 
regulation by BAT-secreted H2O2, by studying mice deficient for Nox4 gene (Nox4-/- 
mice). As shown in Figure 2, H2O2 levels in all investigated adipose depots were 
reduced in Nox4-/- mice (Figure 2B). BAT from Nox4-/- did not exert an anticontractile 
effect on arteries from wild-type mice (Figure 2C), whilst BAT from wild-type mice 
exerted an anticontractile effect on arteries from Nox4-/- mice (Figure 2D), 
demonstrating that the presence of Nox4 in BAT is crucial to induce an 
anticontractile effect, whereas Nox4 localisation in the vessel does not participate in 
the anticontractile effect of BAT. 
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As H2O2 may also be sourced from scavenging of O2.- by superoxide dismutases 
(SOD) we investigated the expression levels of other Nox enzymes that preferentially 
produce O2.- and levels of Sod and catalase (scavenger of H2O2) in BAT. Nox1 
mRNA levels were similar in all adipose depots (Supplementary figure VIII-A) and 
BAT from mice deleted for Nox1 gene exhibited an anticontractile that was not 
different from wild-type BAT (Supplemental Figure X). Nox2 mRNA was lowest in 
BAT (Supplementary figure VIII-B). Sod-1 and Sod-2 mRNA levels were increased in 
BAT and catalase mRNA levels were similar in all depots (Supplemental Figure X). 
Therefore, although a contribution to total BAT H2O2 content from dismutation of O2.- 
by SOD 1-2 cannot be excluded, the O2.- producing enzymes Nox1 and 2 do not 
appear to be major sources of BAT-derived H2O2. 
 
BAT influences vascular function through H2O2-induced activation of PKG-1. 
To investigate molecular mechanisms involved in BAT-induced anticontractility, we 
focused on cyclic GMP-dependent kinase G (PKG)-1, which is activated by reactive 
oxygen species (ROS) such as H2O2 in vascular smooth muscle cells, and which has 
been shown to attenuate vasoconstriction and promote vasodilation.47 The 
anticontractile effect of BAT was abolished in the presence of a potent and selective 
inhibitor of PKG-1α (DT-3) (Figure 3A). Similar effects were obtained after selective 
blockade of BKCa-channels by iberiotoxin (Figures 3B). The anticontractile effect was 
also abolished after PKG-inhibitor Rp-8-Br-PET-cGMP and general blockade of 
Ca2+-sensitive potassium channels by tetraethylammonium (TEA) (Supplementary 
figure VI – C and D). However, the effect of BAT was similar after blockade of NO 
synthesis by Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME) (Figure 3C) 
or of cGMP production by ODQ (Figure 3D), suggesting that the classical NO-
dependent pathway is not involved in mechanisms underlying H2O2-induced 
activation of PKG-1. Previous studies demonstrated that PKG-1 is activated by 
oxidants, which create a disulphide bond in the enzymatic homodimer.48 We found 
that BAT from wild-type mice increased dimerization of PKG-1α but BAT from Nox4-/- 
mice did not (Figure 4A). Furthermore, dithrioethiol (DTT), a reducing agent, 
abolished the anticontractile effect of BAT (Supplemental figure XI). 
The anticontractile effect of BAT was removed by PEG-catalase and IBTX but not 
ODQ also with Phe as the contractile agent (Supplementary figure XII). We also 
investigated the potential role of protein kinase A (PKA) as it may also be activated 
by oxidants in a similar manner to PKG-1. However, PKA inhibition did not alter the 
anticontractile effect of BAT (Supplemental Figure XIII). 
 
BAT reduces activation of MYPT1 and MLC-20. 
To further confirm the anticontractile effect of BAT, we investigated effects of BAT on 
the activations of MYPT1 and MLC-20, downstream proteins ultimately responsible 
for smooth muscle contraction. As shown in Figure 4, incubation of vascular tissue 
with BAT, resulted in significantly reduced phosphorylation of vascular MYPT1 and 
MLC20 (Figures 4B and 4C). 
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Differential mechanisms underlie anticontractile effects of WAT and BAT.  
We further investigated whether the molecular pathway identified for BAT was also 
present in mesenteric PVAT. The anticontractile effect of mesenteric PVAT was 
inhibited by 4-AP but not by PEG-catalase (Supplemental Figure XIV). However, 4-
AP did not prevent the anticontractile of BAT (Supplemental figure VI-A), indicating 
that the anticontractile effects of BAT and mesenteric PVAT are mechanistically 
different. 
Browning of PVAT increases the anticontractile effect through H2O2-dependent 
mechanisms. 
To elucidate whether the changing of PVAT phenotype into a BAT/BeAT phenotype 
affects the anticontractile effect we treated mice with a β3 agonist, CL-316,243, a 
well-established method to induce browning in mice.49 Indeed, β3-treament increased 
BAT/BeAT markers in PVAT (Supplementary figure XV) and PVAT from these 
animals displayed an increased anticontractile effect (Figure 5A). The increased 
anticontractile effect was reduced but not gone after blockade of H2O2 with PEG-
catalase and PKG-1α by DT-3 (Figure 5B and C), indicating that the increased 
anticontractility after browning of resident PVAT is similar in mechanism to that of 
interscapular BAT. 
 
Discussion 
Our study demonstrates that interscapular BAT has anticontractile properties that 
may be vasoprotective. We elucidated putative novel molecular mechanisms 
underlying this process and showed that H2O2, released from BAT activates vascular 
PKG-1α through oxidant-induced dimerization. PKG-1α subsequently 
phosphorylates BKCa channels and reduces phosphorylation of MYPT1 and MLC-20 
with pathways ultimately converging to attenuated vascular contraction. These 
phenomena are BAT-specific since they did not occur in WAT. Importantly, 
increased browning of PVAT enhances the anticontractile effect and this increase 
was shown to be mediated through H2O2.and PKG-1α-dependent mechanisms, 
demonstrating that increasing the amount of resident BAT can affect vascular 
function on small resistance vessels. Our study concludes that BAT induces a potent 
anticontractile effect in small resistant arteries through Nox4-dependent mechanism, 
in particular H2O2-induced activation of PKG-1α-dependent signaling. 
PVAT of thoracic aorta is primarily a BAT phenotype43 and has been shown to exert 
an anticontractile effect, in part through H2O2.1, 26, 44, 50 Gao et al. reported that effects 
of aortic PVAT were prevented by catalase and mimicked by H2O2. This study 
identified two separate pathways of aortic PVAT, an unknown factor inducing 
endothelium-dependent relaxation and that of H2O2 as the endothelium-independent 
mechanism.44 It may be suggested that the presence of two mechanisms might 
reflect the combined effect of both BAT and WAT in aortic PVAT. Mammalian target 
of rapamycin complex 2 (mToRC2) may be partly responsible for aortic PVAT 
function. In animals lacking Rapamycin-insensitive companion of mTOR and thus 
mToRC2, aortic PVAT anticontractility was impaired, possibly mediated through 
increased levels of inflammatory cytokines TNF-α and interleukin-6.51 The observed 
loss of PVAT function was still evident in denuded arteries, supporting an 
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endothelial-independent mechanism for aortic brown PVAT which is in accordance 
with the present study where endothelial denudation did not eliminate the 
anticontractile effect of BAT. 
The central player in our described mechanism, H2O2, has been the focus of intense 
research and its role in the vasculature has been extensively reviewed.52, 53 In the 
vasculature, H2O2 has been suggested to have both detrimental54 and protective 
effects41. These conflicting results may be due to differences in sub-cellular 
localization of H2O2 and other ROS and may relate in part to different cell types 
preferentially producing H2O2.55, 56 In the present study, H2O2 mediates a protective 
role, activating PKG-1α, ultimately resulting in reduced vascular contraction. H2O2 
can originate from the dismutation of O2.- by SOD but also from a dedicated H2O2-
producer: Nox4. Due to its vascular localization,57 constitutively active function and 
production of H2O2, Nox4 is generally regarded as a vaso-protective Nox. Indeed, it 
is highly expressed in BAT and pivotal to the anticontractile effect we observed, as 
BAT from Nox4-/- mice failed to exhibit a vascular effect. However, BAT from wild-
type mice mediated an anticontractile effect on vessels from Nox4-/- mice, suggesting 
that the perivascular production of H2O2 is critical for the anticontractile effect of BAT, 
rather than H2O2 produced locally in smooth muscle cells in the vascular media. -
Also, the need for a threshold level of H2O2 is evident as the H2O2 levels were 
reduced but not abolished in adipose tissue from Nox4-/- mice despite the 
anticontractile effect being abrogated. Importantly, we have previously shown that 
Nox4 is expressed in human adipocytes.58 
In the present study, vessels devoid of PVAT from Nox4-/- mice displayed increased 
contraction and BAT from these mice lacked an anticontractile effect. However, 
Nox4-/- mice display similar blood pressure as wildtype mice under basal conditions 
and after angiotensin II infusion41 and basal blood pressure is reduced only after 
endothelial overexpression of Nox4.59 Taken together, this suggests that Nox4 may 
not be a critical regulator of of blood pressure under basal conditions but may be 
important for blood pressure regulation in conditions were it is increased.  
Whether BAT-derived H2O2 mediates an anticontractile effect or is determined by 
downstream signalling through PKG-1α remains unclear. Importantly, H2O2 is known 
to activate PKG-1α by oxidizing cysteine residues, creating a disulphide bond 
between the PKG-1α homodimers. Subsequently, there is a conformational change 
that exposes the phosphorylation site and downstream signalling occurs. Eaton et al. 
demonstrated that mice that do not activate PKG-1α in this manner, become 
hypertensive under normal conditions,48 demonstrating the importance of the H2O2-
PKG-1α signalling axis in regulating normal blood pressure. In our study, BAT 
induced dimerization of PKG-1α but when dimerization was prevented by DTT the 
anticontractile effect was abolished. Interestingly, blockade of H2O2 to PKG-1α 
signalling by DTT revealed a pro-contractile effect of BAT, suggesting that when the 
beneficial part of H2O2-dependent signalling is removed, remaining signalling or 
other pro-contractile factors such as O2.- can exert a vascular contractile action. 
In our study, blockade of PKG-1α itself or its downstream target, BKCa channels, 
attenuated the anticontractile effect of BAT. This is in accordance with previous 
studies implicating the BKCa channels as mediators of the anticontractile effect of 
adipose tissue.5 Importantly, Withers et al. found the anticontractile effect of PVAT to 
be absent in mice lacking PKG-1.18 
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Our study highlights the fact that various adipose depots have anticontractile 
properties but that underlying molecular mechanisms may differ. Previous studies of 
mesenteric PVAT reported the involvement of voltage-gated K-channels (Kv),60, 61 in 
some cases further specifying it to KCNQ (Kv-7)-channels.9 In the present study, the 
effect of mesenteric PVAT was inhibited by a Kv channel blocker but the 
anticontractile effect of BAT was not affected. Similarly, scavenging of H2O2 removed 
the anticontractile effect of BAT but had no effect on mesenteric PVAT. Additionally, 
inhibition of mechanisms previously shown to be involved in vasoprotective effects of 
PVAT such as H2S, NO, prostacyclins and angiotensin 1-7 had no effect on the 
anticontractile effect of BAT. Taken together, these findings suggest that the 
anticontractile processes of mesenteric PVAT and BAT involve distinct signaling 
pathways. However, it should also be highlighted that mesenteric PVAT could be 
mediated by the small degree of BAT or BeAT within the depots commonly 
characterized as white.62 Originating from white adipocytes63 inactive beige 
adipocytes localized within WAT can be mobilised into BeAT by exposure to cold or 
stimulation of β3-receptors, resulting in a process called browning. Importantly, BeAT 
is morphologically and functionally similar to classical brown adipocytes.64  
Our phenotyping revealed that while EVAT was characterized as WAT, both PVAT 
and iWAT displayed BeAT markers and were thus characterized as a mix of WAT 
and BeAT. Interestingly, iWAT did not display an anticontractile effect and the 
anticontractile effect of PVAT was not affected by PEG-catalase. Either BeAT does 
not behave in a similar manner to BAT in terms of vascular effect, or a critical level of 
BAT or BeAT needs to be present before the anticontractile effect is functional. To 
investigate if an increased amount of BeAT may also exert an anticontractile effect 
we induced browning through a β3-agonist. In these mice, PVAT displayed an 
increased anticontractile effect compared to PVAT from controls, an effect that was 
sensitive to both scavenging of H2O2 and blockade of PKG-1α, suggesting that the 
mechanisms of BAT and BeAT may indeed be similar if a critical threshold of BeAT 
is reached. BAT did not affect vascular relaxation and may relate to the fact that the 
NOS-NO pathway was not influenced by BAT. 
From a pathophysiological viewpoint, our findings may be important since several 
clinical and experimental studies have reported the loss of the PVAT anticontractile 
effect in obesity, type 2 diabetes27-29 and hypertension.23-26 Patients after bariatric 
surgery displayed improved insulin sensitivity, reduced blood pressure and a 
restored anticontractile effect of PVAT.2 Interestingly, BAT surrounding the aorta has 
been reported to be resistant to obesity-induced inflammation, suggesting that BAT 
may help to protect the vasculature during pathological conditions. Furthermore, 
transplantation of BAT into the visceral cavity corrects the metabolic phenotype of 
rodents with diabetes and metabolic syndrome and transplantation of BAT has been 
suggested to be of future importance in metabolic diseases.65-67 Based on the novel 
results of our study, BAT clearly demonstrates a redox-sensitive vasoprotective 
effect and as such exposing small arteries to BAT, or increased browning of PVAT, 
may be an interesting strategy to improve vascular function in pathological 
conditions.  
In conclusion, Nox4 in BAT produces H2O2, leading to oxidant-induced activation of 
PKG-1α and its downstream pathway. This pathway ultimately converges to 
influence signaling that decreases phosphorylation of MYPT1 and MLC-20, with 
consequent reduced vascular contraction. Further, we show that browning of PVAT 
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is feasible, and identify an anticontractile effect through BAT-mediated processes.  
Our study provides new insights into mechanisms whereby BAT may exert 
vasoprotective effects as summarized in Figure 6. These findings have clinical 
significance as a novel therapeutic target, because PVAT-enriched with BAT may 
preserve vascular function and prevent vascular complications in pathologies such 
as hypertension, obesity and metabolic syndrome. 
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Highlights 
 Vascular dysfunction is common feature in hypertension, diabetes and obesity 
and PVAT has emerged as an important regulator of vascular function.  
 The present study demonstrates that BAT can modulate the function of small 
resistance vessels. This anticontractile effect is higher than the one induced 
by PVAT in physiological conditions.  
 The mechanisms identified include Nox4-derived H2O2 from BAT which 
activates PKG-1α and its downstream pathways, resulting in reduced vascular 
contraction.  
 By clearly elucidating the mechanisms of how BAT influences vascular tone, 
our findings provide a rationale to target BAT for new therapeutic strategies 
aiming to preserve vascular function and to prevent vascular complications in 
cardiovascular diseases such as diabetes, obesity and hypertension. 
 
 
 
Figure legends 
Figure 1. A) iWAT does not affect vascular contraction in response to NA. B) EVAT 
and mesenteric PVAT increase EC50 in response to NA. C) BAT increases EC50 and 
reduces MC in response to NA, demonstrating a potent anticontractile effect. D) The 
anticontractile effect of BAT is mediated by a transferrable factor. Values are 
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expressed as means±SD. In brackets are indicated the number of animals per 
group. Repeated measured one-way ANOVA followed by Bonferroni multiple 
comparison test, or Student’s t-test were appropriate. * denotes P<0.05. BAT: brown 
adipose tissue; EC: effective concentration; EVAT: epididymal visceral adipose 
tissue; iWAT: inguinal subcutaneous white adipose tissue; KPSS: potassium-rich 
physiological saline solution; MC: maximal contraction; NA: noradrenaline; PVAT: 
mesenteric perivascular adipose tissue. 
 
Figure 2. A) Presence of PEG-catalase prevents the anticontractile effect of BAT. 
2by2 interaction: p<0.05. B) H2O2 levels are decreased in all adipose depots from 
NOX4-/- mice. C) BAT from Nox4-/- mice does not exert an anticontractile effect. 2by2 
interaction: ns. D) BAT from wild-type exerts an anticontractile effect regardless if the 
vessel is from wild-type or Nox4-/- animals. 2by2 interaction: ns.  
Values are expressed as means±SD. In brackets are indicated the number of 
animals per group. Repeated measured two-way ANOVA, followed by Bonferroni 
multiple comparison test * denotes P<0.05 vs. clean vessels. In B - n=6 animals per 
group. One-way ANOVA, followed by Bonferroni multiple comparison test, * P<0.05 
vs. wildtype within the tissue, # denotes P<0.05 vs. EVAT. BAT: brown adipose 
tissue; EVAT: epididymal visceral adipose tissue; iWAT: inguinal white adipose 
tissue; H2O2: hydrogen peroxide, KPSS: potassium-rich physiological saline solution, 
NA: noradrenaline; Nox4: NADPH oxidase 4; PVAT: perivascular adipose tissue.  
 
Figure 3. A) The anticontractile effect of BAT is blocked by PKG-1α selective inhibitor 
DT-3 (2by2 interaction: p<0.05) and B) the selective BKCa channel blocker IBTX 
(2by2 interaction: p<0.05). C) The anticontractile effect is not affected NOS-inhibitor 
L-NAME (2by2 interaction: ns) or by soluble guanylate cyclase inhibitor ODQ (D, 
2by2 interaction: p<0.05). Values are expressed as means±SD. In brackets are 
indicated the number of animals per group. Repeated measured two-way ANOVA, 
followed by Bonferroni multiple comparison test, * denotes P<0.05 vs. clean vessels. 
BAT: brown adipose tissue; BKCa: big conductance calcium-sensitive potassium 
channel; IBTX: iberiotoxin; KCa: calcium-sensitive potassium channel; KPSS: 
potassium-rich physiological saline solution; L-NAME: Nω-Nitro-L-arginine methyl 
ester hydrochloride; NA: noradrenaline. 
 
Figure 4. A) Dimerization of PKG-1α is induced by BAT from wild-type mice but not 
by BAT from Nox4-/- mice. (B) Phosphorylation of MYPT1 and MLC20 (C) is 
decreased by BAT from wild-type mice WT but not with BAT from Nox4-/- mice. 
Values are expressed as means±SD. n=4-6 animals per group. One-way ANOVA, 
followed by Bonferroni multiple comparison test, * denotes P<0.05 vs. clean. BAT: 
brown adipose tissue; DTT: dithioethriethol; H2O2: hydrogen peroxide; MLC20: 
myosin light chain 20; MYPT1: myosin light chain phosphatase regulatory subunit 1; 
Nox4: NADPH oxidase 4. 
 
Figure 5. A) Browning of PVAT increases the anticontractile effect (2by2 interaction: 
p<0.05 B). The anticontractile effect in the β3-agonist treated mice is diminished by 
PEG-catalase (2by2 interaction: p<0.05) and by C) PKG-Iα inhibitor DT-3 (2by2 
interaction: p<0.05). Values are expressed as means±SD. In brackets are indicated 
the number of animals per group. Repeated measured two-way ANOVA, followed by 
Bonferroni multiple comparison test, * denotes P<0.05 vs. clean vessels. KPSS: 
 
 
17 
potassium-rich physiological saline solution; NA: noradrenaline; PEG: 
polyethyleneglykol; PVAT: perivascular adipose tissue. 
Figure 6. Summarized scheme of proposed mechanisms whereby BAT may induce 
vasoprotective effects. BKCa: big conductance calcium-sensitive potassium channel; 
cGMP: cyclic GMP; DTT: dithioethrethiol; eNOS: endothelial nitric oxide synthase; 
H2O2: hydrogen peroxide; MLC: myosin light chain; MLCK: myosin light chain kinase; 
MLCP: myosin light chain phosphatase; MYPT1: myosin light chain phosphatase 
regulatory subunit 1; NO: nitric oxide; Nox4: NADPHoxidase 4; ROCK: Rho kinase; 
sGC: soluble guanylate cyclase; TEA:  tetraethylammonium; VDCC: voltage 
dependent calcium channel. 
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SUPPLEMENTAL MATERIAL 
 
Brown adipose tissue regulates small artery function through NADPH oxidase 
4-derived hydrogen peroxide and redox-sensitive protein kinase G-1α. 
 
Friederich-Persson M, Nguyen Dinh Cat A, Persson P, Montezano AC, Touyz RM. 
Institute of Cardiovascular Medicine and Sciences, University of Glasgow, Glasgow,  
United Kingdom. 
 
Supplementary table 
Table 1. Mouse primer sequences for real time PCR.  
Gene Forward 5’-3’ Reverse 3’-5’ 
mSod1 GAGACCTGGGCAATGTGACT TTGTTTCTCATGGACCACCA 
mSod2 GGCCAAGGGAGATGTTACAA GCTTGATAGCCTCCAGCAAC 
mCatalase ACATGGTCTGGGACTTCTGG CAAGTTTTTGATGCCCTGGT 
mFbx10 AAGTATGCCTCCAACCTGCC TTTTTGGGGTGCTCGTCTGA 
mUbc GGTCAAACAGGAAGACAGACGTA CACACCCAAGAACAAGCACA 
mIpo8 ACCAGGACCCGTCACGTCG ATCCACGGCAGGAGGTCGGT 
mNox1 TCCCTTTGCTTCCTTCTTGA CCAGCCAGTGAGGAAGAGTC  
mNox2 CGCCCTTTGCCTCCATTCTC  CCTTTCCTGCATCTGGGTCTCC  
mNox4 CCAGAATGAGGATCCCAGAA  AGCAGCAGCAGCATGTAGAA  
mUcp-1 GGGCCCTTGTAAACAACAAA GTCGGTCCTTCCTTGGTGTA 
mTmem-26 GTGACCTGGGTGAAGGAAGA TGCATTTCAAGAAGCCACAG 
mLeptin ATGTGCTGGAGACCCCTGTG TCAGCATTCAGGGCTAACATCC 
mCD137 CGTGCAGAACTCCTGTGATAAC GTCCACCTATGCTGGAGAAGG 
mP2Rx5 CTGCAGCTCACCATCCTGT CACTCTGCAGGGAAGTGTCA 
mPat2 ACAGGGATCCTCGGACTTC GAGGCCCATTACCAGCAAG 
mTbx1 GGCAGGCAGACGAATGTTC TTGTCATCTACGGGCACAAAG 
mTcf21 CATTCACCCAGTCAACCTGA TTCCTTCAGGTCATTCTCTGG 
mZiz1 AACCTCAAGATCCACAAAAGGA CCTCGAACTCGCACTTGAA 
   
   
 
CD137: tumor necrosis factor receptor superfamily member 9; FBX10: F-box and 
leucine-rich repeat protein-10; Ipo8: importin 8; m: mouse; Nox: NADPH oxidase; 
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Ubc: ubiquitin C; Ucp: uncoupling protein;  P2RX5: purinergic Receptor P2X 5; Sod: 
superoxide dismutase; Tbx1: T-box protein 1; tcf21: transcription factor 21;Tmem-26: 
transmembrane protein 26; Zic1: Zinc finger of the cerebellum. 
Supplemental figures and legends 
 
 
 
 
 
 
Supplemental Figure I. A) Joint BAT and BeAT marker Ucp-1 is expressed in BAT 
and iWAT but at low levels in PVAT and EVAT. Specific BAT marker Zic1 (B) and 
P2RX5  (C) is expressed in solely BAT. D) Joint BAT and BeAT marker Pat2 is 
expressed in iWAT, PVAT and BAT. Values are expressed as means±SD. N=6-8 
animals per group. One-way ANOVA, followed by Bonferroni multiple comparison 
test, * P<0.05 vs. EVAT, BAT: brown adipose tissue; BeAT: beige adipose tissue; 
EVAT: epididymal visceral adipose tissue; iWAT: inguinal subcutaneous white 
adipose tissue; P2RX5: purinergic receptor 2X; PVAT: perivascular adipose tissue; 
Ucp-1: uncoupling protein 1; WAT: white adipose tissue; Zic: zinc finger of the 
cerebellum. 
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Supplemental Figure II. Specific BeAT markers Tmem-26 (A) and CD137 (B) are 
expressed in BAT and iWAT but at low levels in PVAT and EVAT. C) Specific BeAT 
marker Tbx1expressed in iWAT and PVAT. Values are expressed as means±SD. 
N=6-8 animals per group. One-way ANOVA, followed by Bonferroni multiple 
comparison test, * P<0.05 vs. EVAT, BAT: brown adipose tissue; BeAT: beige 
adipose tissue; EVAT: epididymal visceral adipose tissue; iWAT: inguinal 
subcutaneous white adipose tissue; PVAT: perivascular adipose tissue; Tbx: T-box 
protein; Tmem: transmembrane; WAT: white adipose tissue. 
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Supplemental Figure III. (A) WAT marker leptin is expressed in EVAT. B) Specific 
WAT marker Tcf21 is expressed in EVAT and PVAT. Values are expressed as 
means±SD. N=6-8 animals per group. One-way ANOVA, followed by Bonferroni 
multiple comparison test, * P<0.05 vs. EVAT, BAT: brown adipose tissue; EVAT: 
epididymal visceral adipose tissue; iWAT: inguinal subcutaneous white adipose 
tissue; PVAT: perivascular adipose tissue; Tcf: transcription factor; WAT: white 
adipose tissue. 
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Supplemental Figure IV. The anticontractile effect of BAT is evident in response to 
both Phe (A, 2by2 interaction: ns) and 5-HT (B, 2by2 interaction: ns). The 
anticontractile effect of BAT is similar regardless of gender (C, 2by2 interaction: ns) 
and strain (D (2by2 interaction: ns). Values are expressed as means ± SD. In 
brackets are indicated the number of animals per group. Repeated measured two-
way ANOVA, followed by Bonferroni multiple comparison test, * P<0.05 vs clean 
vessels. 5-HT: 5-hydroxytryptamine; BAT: brown adipose tissue; NA: noradrenaline; 
KPSS: potassium-rich physiological saline solution; Phe: phenylephrine. 
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Supplemental Figure V. The anticontractile effect of BAT is not affected by voltage-
gated K-channels by 4-AP blockade (A, 2by2 interaction: p<0.05) or XE-991 (B, 2by2 
interaction: p<0.05), angiotensin 1-7 receptor blockade by A779 (C, 2by2 interaction: 
ns) or blockage of  γ-cystathione lyase (producer of H2S) inhibition by β-cyanoalanine 
(β-cyano) (D, 2by2 interaction: ns). Values are expressed as means ± SD. In 
brackets are indicated the number of animals per group. Repeated measured two-
way ANOVA, followed by Bonferroni multiple comparison test, * P<0.05 vs. clean 
vessels. 4-AP: 4-aminopyridine; β-cyano: β-cyanoalanine; BAT: brown adipose 
tissue; H2S; hydrogen sulphide; KPSS: potassium-rich physiological saline solution; 
NA: noradrenaline. 
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Supplemental Figure VI. The anticontractile effect of BAT is not affected by removal 
of the endothelium (A, 2by2 interaction: ns), indomethacin (B, 2by2 interaction: ns). 
The anticontractile effect was blocked by PKG-inhibitor Rp-8-Br-PET-cGMP (C, 2by2 
interaction: p<0.05) and calcium-sensitive potassium channel blocker TEA (D, 2by2 
interaction: p<0.05). Values are expressed as means ± SD. In brackets are indicated 
the number of animals per group. Repeated measured two-way ANOVA, followed by 
Bonferroni multiple comparison test, * P<0.05 vs. clean vessels. BAT: brown adipose 
tissue; KPSS: potassium-rich physiological saline solution; NA: noradrenaline; PKG: 
protein kinase G; TEA: tetraethylammonium. 
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Supplemental Figure VII. A) BAT does not affect endothelium-dependent relaxation 
in response to ACh. B) BAT does not affect endothelium-independent relaxation in 
response to SNP. Values are expressed as means ± SD. In brackets are indicated 
the number of animals per group. Bar graphs show level of preconstriction in 
response to NA. ACh: acetylcholine; BAT: brown adipose tissue; KPSS: potassium-
rich physiological saline solution; NA: noradrenaline; SNP: sodium nitroprusside. 
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Supplemental Figure VIII. Figure 2. A) Nox1 expression does not vary between 
adipose depots. B) Nox2 expression is decreased in BAT. C) Nox4 is increased in 
iWAT and BAT. D) Nox 4 protein level is increased in BAT. Values are expressed as 
means ± SD. A-C: n=8 animals per group, D: n=3-7 per group. One-way ANOVA, 
followed by Bonferroni multiple comparison test, * P<0.05 vs. EVAT. BAT: brown 
adipose tissue; EVAT: epididymal visceral adipose tissue; iWAT: inguinal white 
adipose tissue; PVAT: perivascular adipose tissue. 
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Supplemental Figure IX. BAT from Nox1-/- mice exerts a similar anticontractile effect 
as BAT from wildtype mice. Values are expressed as means ± SD. In brackets are 
indicated the number of animals per group. One-way ANOVA, followed by Bonferroni 
multiple comparison test, * P<0.05 vs. clean vessels. BAT: brown adipose tissue; 
KPSS: potassium-rich physiological saline solution; NA: noradrenaline; Nox: NADPH 
oxidase. 
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Supplemental Figure X. BAT displayed increased mRNA levels of Sod1 (A) and Sod2 
(B). Catalase mRNA levels were not changed between adipose depots (C). Values 
are expressed as means ± SD. n=8 animals per group. One-way ANOVA, followed 
by Bonferroni multiple comparison test, * P<0.05 vs EVAT. BAT: brown adipose 
tissue; EVAT: epididymal visceral adipose tissue; iWAT: inguinal subcutaneous white 
adipose tissue; PVAT: perivascular adipose tissue; Sod: superoxide dismutase. 
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Supplemental Figure XI. DTT prevents the anticontractile effect of BAT. Values are 
expressed as means ± SD. In brackets are indicated the number of animals per 
group. Repeated measured two-way ANOVA, followed by Bonferroni multiple 
comparison test, * P<0.05 vs. clean vessels, 2by2 interaction: p<0.05. BAT: brown 
adipose tissue; DTT: dithiotreitol; KPSS: potassium-rich physiological saline solution; 
NA: noradrenaline. 
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Supplemental Figure XII. Using phenylephrine as the contractile agent, the 
anticontractile effect of BAT is removed by PEG-catalase (A, 2by2 interaction: 
p<0.05) and IBTX (B, 2by2 interaction: p<0.05) but not by ODQ (C, 2by2 interaction: 
ns). Values are expressed as means ± SD. In brackets are indicated the number of 
animals per group. Repeated measured two-way ANOVA, followed by Bonferroni 
multiple comparison test, * P<0.05 vs. clean vessels. BAT: brown adipose tissue; 
IBTX: iberiotoxin; KPSS: potassium-rich physiological saline solution; PEG: 
polyethyleneglykol; Phe: phenylephrine. 
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Supplemental Figure XIII. Protein kinase A inhibition by PKI 5-24 (A, 2by2 
interaction:ns) or KT-5720 (B, 2by2 interaction: p<0.05) does not affect the 
anticontractile effect of BAT. Values are expressed as means ± SD. In brackets are 
indicated the number of animals per group. Repeated measured two-way ANOVA, 
followed by Bonferroni multiple comparison test, * P<0.05 vs clean vessels. BAT: 
brown adipose tissue; KPSS: potassium-rich physiological saline solution; NA: 
noradrenaline. 
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Supplemental Figure XIV. The anticontractile effect of mesenteric PVAT is prevented 
after blockade of Kv-channels (A, 2by2 interaction: p<0.05) and not affected by H2O2 
scavenging by PEG-catalase (B, 2by2 interaction: ns). Values are expressed as 
means ± SD. In brackets are indicated the number of animals per group. Repeated 
measured two-way ANOVA, followed by Bonferroni multiple comparison test, * 
P<0.05 vs. clean. 4-AP: 4-aminopyridine; BAT: brown adipose tissue; KPSS: 
potassium-rich physiological saline solution; Kv-channel: voltage gated potassium-
channel; PEG: polyethylene glycated; PVAT: perivascular adipose tissue. 
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Supplemental Figure XV. Mesenteric PVAT obtained from mice treated with β3-
agonist Cl-316,243 display increased of joint BAT and BeAT marker Ucp1 (A) as well 
as specific BeAT markers tmem-26 (B), Tbx1 (B) and CD137 (D). Values are 
displayed as mean ± SD, N=5-7 per group. * P<0.05 vs PVAT, Student’s t-test. BAT: 
brown adipose tissue; BeAT: beige adipose tissue; PVAT: perivascular adipose 
tissue; tbx: T-box protein; tmem: transmembrane protein; ucp: uncoupling protein. 
